Im, S H <br/><br/>
Suppression of experimental myasthenia gravis, a B cell-mediated autoimmune disease, by blockade of IL-18.  [electronic resource] 

 -  FASEB journal : official publication of the Federation of American Societies for Experimental Biology  Oct 2001 
 - 2140-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1530-6860 
<br/><br/><label>Standard No.: </label>10.1096/fj.01-0072com  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Abatacept<br/>Animals<br/>Antibodies--therapeutic use<br/>Antigens, CD<br/>Antigens, Differentiation--biosynthesis<br/>B-Lymphocytes--immunology<br/>CD40 Ligand--metabolism<br/>CTLA-4 Antigen<br/>Cells, Cultured<br/>Cytokines--biosynthesis<br/>Disease Progression<br/>Female<br/>Hypersensitivity, Delayed--therapy<br/>Immunoconjugates<br/>Immunoglobulin G--biosynthesis<br/>Interleukin-18--antagonists & inhibitors<br/>Kinetics<br/>Lymphocyte Activation<br/>Myasthenia Gravis, Autoimmune, Experimental--immunology<br/>Rats<br/>Rats, Inbred Lew<br/>Receptors, Nicotinic--immunology<br/>T-Lymphocytes--immunology<br/>Th1 Cells--immunology<br/>Transforming Growth Factor beta--biosynthesis